MTAR Tech: Nuclear Boom Fuels Shareholder Gains

The Shanti Bill boosts India's nuclear power push, opening doors for private firms like MTAR Technologies. This precision engineering leader makes critical parts for reactors, fueling machines, and coolant systems in Pressurized Heavy Water Reactors. For shareholders, it means steady order growth in a sector eyeing 22.8 GW by 2032 and 100 GW by 2047.​

supplies 20-25% of equipment needs for a 700 MWe plant, including end shields and calandria. New facilities handle four reactors at once for builds and refurbishments. Government plans 14 new reactors and five refurbishments create multi-year demand. Recent wins like Rs 194 Cr from Megha Engineering and Rs 370 Cr amended order build a Rs 1,297 Cr book, with nuclear at Rs 150 Cr.​ Near-term, Rs 800 Cr orders by FY26 end include Rs 500 Cr for Kaiga 5&6, executable in three years. Medium-term adds Rs 1,000 Cr from more projects; long-term Rs 1,500-2,000 Cr over 6-7 years. H1 FY26 nuclear revenue hit Rs 10.5 Cr from Rs 18.4 Cr yearly prior. Small modular reactors by 2033 open fresh avenues.​​ This benefits shareholders hugely. Nuclear now 2.7% of revenue but poised for 35-40% yearly growth from FY27 on policy tailwinds and execution. Strong 17.4% RoCE shows capital efficiency, though 7.5% RoE lags due to reinvestments. At 158x P/E versus 74x median, premium reflects visibility but risks corrections if delays hit.​ High valuation demands caution amid lumpy orders and competition, yet debt-free status and 41.9% YTD stock rise prove upside. Patient holders gain from compounding in India's clean energy shift, outweighing short-term volatility. Overall, Shanti Bill makes MTAR highly valuable, not detrimental.